You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Pedestrian Auto Enforcement Program (PAEP)

    SBC: POLARIS SENSOR TECHNOLOGIES INC            Topic: 122FH3

    We propose an innovative Pedestrian Automotive System for Enforcement and Safety (PASES) that combines commercial-off-the-shelf video or camera components and state-of-the-art microwave(radar) systems with sophisticated software that will not only provide more effective enforcement through effective evidentiary information, but will also enable predictive actions based on vehicle and pedestrian be ...

    SBIR Phase I 2013 Department of Transportation
  2. High Speed Imaging Spectropolarimeter for Dynamic Samples

    SBC: POLARIS SENSOR TECHNOLOGIES INC            Topic: 9020663R

    Spectroscopic ellipsometry is recognized as the gold standard in noncontact characterization of the refractive index and thickness of a thin optical film or film stack on a substrate. However, it suffers from a number of shortcomings, perhaps the most important of which is the time required to perform a single measurement. Moreover, manufacturers are interested in comprehensive evaluation of thin ...

    SBIR Phase I 2013 Department of CommerceNational Institute of Standards and Technology
  3. New drug VS-110 for treating inflammatory bowel diseases

    SBC: Vidasym, Inc            Topic: NIDDK

    DESCRIPTION (provided by applicant): Inflammatory bowel diseases (IBD) involve chronic inflammation of all or part of the digestive tract. Symptoms may include abdominal pain, severe diarrhea and malnutrition. IBD primarily includes ulcerative colitis (UC)and Crohn's disease (CD). In the West, the prevalence has increased in the past 50 years to 120-200/100,000 persons for UC and 50-200/100,0 ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Nanocytological Fecal Assessment to Personalize Colonoscopic Surveillance

    SBC: NANOCYTOMICS LLC            Topic: NCI

    DESCRIPTION (provided by applicant): The clinical impact of the 5 million annual surveillance colonoscopies (follow up of previous neoplasia) is remarkably low (gt90% without significant neoplasia). Juxtaposed with this is the alarmingly frequent occurrence of colorectal cancers (CRCs) in between colonoscopies (interval cancers), especially in the proximal colon. The medico-legal and clinical con ...

    STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Fluorescence Intensity-based Scoring of Macromolecule Crystallization Plates

    SBC: iXpressGenes, Inc.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Crystallization, followed by subsequent structure determination, is a major step in understanding the structure- function relationship of macromolecules. Understanding macromolecule structure has become a key part in the development of new pharmaceuticals, and is a major area of NIH research. Crystallization however is also the rate limiting step, despite techn ...

    STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  6. Novel SET Antagonists for the Treatment of Chronic Myelogenous Leukemia

    SBC: UNITED STATE DRUG TESTING LABORATORIES, INC.            Topic: NIAAA

    PROJECT SUMMARY Prenatal alcohol exposure is the leading preventable cause of birth defects in the United States, producing an array of neurological, behavioral and physical abnormalities collectively known as fetal alcohol spectrum disorders (FASD). Earlyintervention and treatment programs have been shown to reduce some of the long-term adverse effects, but this is dependent on identifying childr ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Clinical Development of a Stable Glucagon Formulation for Bi-hormonal Pump

    SBC: Vidasym, Inc            Topic: NIAMS

    DESCRIPTION (provided by applicant): Osteoporosis is a major public health threat. National Osteoporosis Foundation estimated that the US national direct expenditures for osteoporotic hip fractures were at 17 billion in 2005 and it would increase to 25billion in 2025. Current treatments for osteoporosis include several anti-resorptive (or anti-catabolic) and some anabolic agents. VDRMs such as ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Restoring arm and hand motor function with non-invasive spinal stimulation.

    SBC: Q-Track Corporation            Topic: NIAMS

    DESCRIPTION (provided by applicant): Q-Track seeks to develop a Sports Medicine Assessment Tool (SMAT) to provide comprehensive kinematic and physiological data to trainers, coaching staff, and athletes. In addition to the safety benefit of monitoring thevital condition of players in real time, our goal is to develop a fatigue management system. The purpose of this proposal is to integrate kinema ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Diametrically Patterned Dural Graft for Enhanced Dura Mater Regeneration

    SBC: ACOUSTIC MEDSYSTEMS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Prostate cancer affects one in every six men and remains the second leading cause of cancer related mortality in men. Permanent interstitial brachytherapy, the permanent placement of radioactive seeds in the prostate, is widely used in the treatment of prostate cancer. Despite the recent uptake in robotic surgery (with reported increased urinary morbidity) whic ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Screens for Novel Agonists/Antagonists of Endocrine Fibroblast Growth Factors

    SBC: GLUCOSENTIENT INC            Topic: NIDA

    DESCRIPTION: Substance use disorder (SUD) is a major health problem with direct and indirect impact on healthcare and societal cost that is estimated at over 181 billion annually in the United States. Opioids are the second most abused substances and buprenorphine (BUP) is an effective and safe medication for opioid dependence. However, BUP remains a narcotic, and strict BUP compliance is critic ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government